-
Je něco špatně v tomto záznamu ?
Oligomycins A and C, major secondary metabolites isolated from the newly isolated strain Streptomyces diastaticus
Yang PW, Li MG, Zhao JY, Zhu MZ, Shang H, Li JR, Cui XL, Huang R, Wen ML.
Jazyk angličtina Země Česko
- MeSH
- Alternaria účinky léků MeSH
- antifungální látky farmakologie chemie izolace a purifikace MeSH
- Aspergillus niger účinky léků MeSH
- Botrytis účinky léků MeSH
- chromatografie kapalinová metody MeSH
- DNA bakterií genetika chemie MeSH
- financování organizované MeSH
- fylogeneze MeSH
- molekulární sekvence - údaje MeSH
- oligomyciny farmakologie chemie izolace a purifikace MeSH
- Phytophthora účinky léků MeSH
- ribozomální DNA genetika chemie MeSH
- RNA ribozomální 16S genetika MeSH
- sekvenční analýza DNA MeSH
- shluková analýza MeSH
- spektrální analýza metody MeSH
- Streptomyces MeSH
During the screening program for fungicides, one actinomycete strain ECO 00047 was isolated with the potential activity against fungus. According to the morphology and analysis of the nucleotide sequence of the 16S rRNA gene (1500 bp) this isolate was identified as Streptomyces diastaticus. The active compounds were separated by silica gel column chromatography, Sephadex LH-20 gel filtration and then purified by flash chromatography on C18 (20-45 microm). The chemical structure of the bioactive compounds I and II were elucidated, based on the spectroscopic data of MS, IR, UV, 1H-NMR, 13C-NMR and X-ray single crystal diffraction analysis. Compounds I and II were identical with oligomycins A and C, the macrolide antibiotics which have been known to be produced by Streptomyces diastatochromogenes, S. libani and S. avermitilis. The two compounds exhibited a strong activity against Aspergillus niger, Alternaria alternata, Botrytis cinerea and Phytophthora capsici but no activity toward bacteria. Although the two above antibiotics were known, their isolation has so far not been reported from S. diastaticus.
Lit.: 47
- 000
- 00000naa 2200000 a 4500
- 001
- bmc10012966
- 003
- CZ-PrNML
- 005
- 20111210163351.0
- 008
- 100531s2010 xr e eng||
- 009
- AR
- 040 __
- $a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xr
- 100 1_
- $a Yang, P. W.
- 245 10
- $a Oligomycins A and C, major secondary metabolites isolated from the newly isolated strain Streptomyces diastaticus / $c Yang PW, Li MG, Zhao JY, Zhu MZ, Shang H, Li JR, Cui XL, Huang R, Wen ML.
- 314 __
- $a Key Laboratory for Microbial Resources, Ministry of Education, and Laboratory for Conservation and Utilization of Bio-Resources, Yunnan Institute of Microbiology, Yunnan University, Kunming, Yunnan
- 504 __
- $a Lit.: 47
- 520 9_
- $a During the screening program for fungicides, one actinomycete strain ECO 00047 was isolated with the potential activity against fungus. According to the morphology and analysis of the nucleotide sequence of the 16S rRNA gene (1500 bp) this isolate was identified as Streptomyces diastaticus. The active compounds were separated by silica gel column chromatography, Sephadex LH-20 gel filtration and then purified by flash chromatography on C18 (20-45 microm). The chemical structure of the bioactive compounds I and II were elucidated, based on the spectroscopic data of MS, IR, UV, 1H-NMR, 13C-NMR and X-ray single crystal diffraction analysis. Compounds I and II were identical with oligomycins A and C, the macrolide antibiotics which have been known to be produced by Streptomyces diastatochromogenes, S. libani and S. avermitilis. The two compounds exhibited a strong activity against Aspergillus niger, Alternaria alternata, Botrytis cinerea and Phytophthora capsici but no activity toward bacteria. Although the two above antibiotics were known, their isolation has so far not been reported from S. diastaticus.
- 650 _2
- $a financování organizované $7 D005381
- 650 _2
- $a Alternaria $x účinky léků $7 D000528
- 650 _2
- $a antifungální látky $x farmakologie $x chemie $x izolace a purifikace $7 D000935
- 650 _2
- $a Aspergillus niger $x účinky léků $7 D001234
- 650 _2
- $a Botrytis $x účinky léků $7 D020171
- 650 _2
- $a chromatografie kapalinová $x metody $7 D002853
- 650 _2
- $a shluková analýza $7 D016000
- 650 _2
- $a DNA bakterií $x genetika $x chemie $7 D004269
- 650 _2
- $a ribozomální DNA $x genetika $x chemie $7 D004275
- 650 _2
- $a molekulární sekvence - údaje $7 D008969
- 650 _2
- $a oligomyciny $x farmakologie $x chemie $x izolace a purifikace $7 D009840
- 650 _2
- $a fylogeneze $7 D010802
- 650 _2
- $a Phytophthora $x účinky léků $7 D010838
- 650 _2
- $a RNA ribozomální 16S $x genetika $7 D012336
- 650 _2
- $a sekvenční analýza DNA $7 D017422
- 650 _2
- $a spektrální analýza $x metody $7 D013057
- 650 _2
- $a Streptomyces $7 D013302
- 700 1_
- $a Li, M. G.
- 700 1_
- $a Zhao, J. Y.
- 700 1_
- $a Zhu, M. Z.
- 700 1_
- $a Shang, H.
- 700 1_
- $a Li, J. R.
- 700 1_
- $a Cui, X. L.
- 700 1_
- $a Huang, R.
- 700 1_
- $a Wen, M. L.
- 773 0_
- $w MED00011005 $t Folia microbiologica $g Roč. 55, č. 1 (2010), s. 10-16 $x 0015-5632
- 856 41
- $u http://www.springerlink.com/content/17qw61l274x26545/fulltext.pdf $y plný text volně přístupný
- 910 __
- $a ABA008 $b A 2403 $c 561 $y 8
- 990 __
- $a 20100531103706 $b ABA008
- 991 __
- $a 20101124082819 $b ABA008
- 999 __
- $a ok $b bmc $g 726820 $s 589997
- BAS __
- $a 3
- BMC __
- $a 2010 $b 55 $c 1 $d 10-16 $m Folia microbiologica $x MED00011005
- LZP __
- $a 2010-15/mkme